One hypothesis for this result is that BRAF and KRAS mutations were almost mutually exclusive in CRC and MSI tumors are more likely to harbor a BRAF mutation, so MSS tumors might harbor more KRAS mutations (Naguib et al., 2010). Here, KRAS is linked to colorectal carcinoma.